Provence Wealth Management Group Makes New $276,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Provence Wealth Management Group acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 819 shares of the medical equipment provider’s stock, valued at approximately $276,000.

A number of other institutional investors have also made changes to their positions in ISRG. OFI Invest Asset Management acquired a new stake in shares of Intuitive Surgical in the third quarter valued at about $25,000. Baystate Wealth Management LLC grew its holdings in Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares during the last quarter. MCF Advisors LLC increased its position in Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 40 shares during the period. Headinvest LLC acquired a new position in shares of Intuitive Surgical during the third quarter worth approximately $28,000. Finally, Stone House Investment Management LLC grew its stake in shares of Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded up $3.71 during trading on Friday, hitting $381.36. 1,028,858 shares of the company were exchanged, compared to its average volume of 1,492,254. The firm has a market capitalization of $135.27 billion, a P/E ratio of 68.84, a price-to-earnings-growth ratio of 4.88 and a beta of 1.39. The firm’s fifty day moving average price is $385.40 and its 200 day moving average price is $349.30. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the prior year, the firm earned $1.00 earnings per share. The business’s quarterly revenue was up 11.5% on a year-over-year basis. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on ISRG shares. Citigroup increased their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Raymond James upped their price target on Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a research report on Thursday, January 25th. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research note on Friday, April 19th. BTIG Research lifted their price target on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a report on Friday, April 19th. Finally, Piper Sandler raised their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a report on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $396.17.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 196 shares of Intuitive Surgical stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the transaction, the senior vice president now owns 1,842 shares in the company, valued at approximately $736,800. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Intuitive Surgical news, SVP Mark Brosius sold 196 shares of the stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now owns 1,842 shares in the company, valued at approximately $736,800. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the sale, the director now owns 25,319 shares in the company, valued at $9,385,753.30. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 226,928 shares of company stock worth $87,833,828. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.